DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...

Bearish flow noted in DexCom (DXCM) with 11,940 puts trading, or 4x expected. Most active are 12/27 weekly 59 puts and 12/27 weekly 77 puts, ...

The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

DexCom Inc (DXCM) stock saw a decline, ending the day at $77.72 which represents a decrease of $-1.20 or -1.52% from the prior close of $78.92. The stock opened at $79.21 and touched a low of $77.33 ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

Unfortunately for shareholders, while the DexCom, Inc. (NASDAQ:DXCM) share price is up 56% in the last five years, that's less than the market return. Zooming in, the stock is actually down 34% in ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.